CooperCompanies to Participate in the William Blair Growth Stock Conference
CooperCompanies (Nasdaq: COO), a global medical device firm, is set to participate in the William Blair Growth Stock Conference on June 5, 2024.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
CooperCompanies (Nasdaq: COO), a global medical device firm, is set to participate in the William Blair Growth Stock Conference on June 5, 2024. Dan McBride, Executive Vice President & Chief Operating Officer, will represent the company in a session at 11:00 AM ET. Interested parties can view the webcast via the CooperCompanies' investor website.
Positive
- CooperCompanies' participation in a prestigious conference could increase visibility among investors.
- Representation by a top executive, Dan McBride, signals the company's commitment to investor relations.
Negative
- No new financial data or business developments were announced, which may not satisfy investors looking for substantial updates.
Details
News Market Reaction – COO
The recorded move for COO in the trading session of this news was +2.02%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN RAMON, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, will participate in the William Blair Growth Stock Conference on Wednesday, June 5, 2024. Dan McBride, Executive Vice President & Chief Operating Officer, will represent the Company in a session scheduled at 11:00 AM ET.
The webcast will be available to investors and other interested parties by accessing the CooperCompanies’ website at http://investor.coopercos.com.
About CooperCompanies
CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on improving lives one person at a time. The Company operates through two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, improving the vision of millions of people every day. CooperSurgical is a leading fertility and women’s health company dedicated to assisting women, babies and families at the healthcare moments that matter most. Headquartered in San Ramon, CA, CooperCompanies (“Cooper”) has a workforce of more than 15,000 with products sold in over 130 countries. For more information, please visit www.coopercos.com.
Contact:
Kim Duncan
Vice President, Investor Relations and Risk Management
925-460-3663
ir@cooperco.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.